Interesting to see how the pharmaceutical companies are responding to health care reform efforts in Washington. The first quarter of this year their spending on lobbying jumped +36% from the same period in 2008. They spent $47.4 million in the first three months of the year to influence our elected officials not to ruin their party.
At the same time the Insurance industry decreased lobbying expenses by 2% to just $41.4 million for the first quarter. Either they're keeping their powder dry or they accept that change in health care is inevitable this time around are are willing to work with the process.